ClinicalTrials.Veeva

Menu
H

Hospital General Universitario de Alicante Doctor Balmis | Cardiology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Upadacitinib
Risankizumab
Cefiderocol
Dupilumab
Ustekinumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 7 total trials

Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) (SEQUENCE)

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. This study will evaluate how well risankiz...

Active, not recruiting
Crohn's Disease (CD)
Drug: Risankizumab
Drug: Ustekinumab

Trial sponsors

AbbVie logo
Shionogi logo
Ó

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems